305 related articles for article (PubMed ID: 28264054)
41. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
Agrawal L; Vanhorn-Ali Z; Alkhatib G
J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
[TBL] [Abstract][Full Text] [Related]
42. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
[TBL] [Abstract][Full Text] [Related]
43. Role of low CD4 levels in the influence of human immunodeficiency virus type 1 envelope V1 and V2 regions on entry and spread in macrophages.
Walter BL; Wehrly K; Swanstrom R; Platt E; Kabat D; Chesebro B
J Virol; 2005 Apr; 79(8):4828-37. PubMed ID: 15795268
[TBL] [Abstract][Full Text] [Related]
44. Blood monocytes harbor HIV type 1 strains with diversified phenotypes including macrophage-specific CCR5 virus.
Xu Y; Zhu H; Wilcox CK; van't Wout A; Andrus T; Llewellyn N; Stamatatos L; Mullins JI; Corey L; Zhu T
J Infect Dis; 2008 Jan; 197(2):309-18. PubMed ID: 18173363
[TBL] [Abstract][Full Text] [Related]
45. Short communication: severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regions.
Seclén E; Soriano V; del Mar González M; González-Lahoz J; Poveda E
AIDS Res Hum Retroviruses; 2011 Sep; 27(9):965-7. PubMed ID: 21314481
[TBL] [Abstract][Full Text] [Related]
46. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.
Pandey D; Podder A; Pandit M; Latha N
J Biomol Struct Dyn; 2017 Sep; 35(12):2631-2644. PubMed ID: 27545652
[TBL] [Abstract][Full Text] [Related]
47. HIV-1 attachment: another look.
Ugolini S; Mondor I; Sattentau QJ
Trends Microbiol; 1999 Apr; 7(4):144-9. PubMed ID: 10217828
[TBL] [Abstract][Full Text] [Related]
48. T cell-tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis.
Iyengar S; Schwartz DH; Hildreth JE
J Immunol; 1999 May; 162(10):6263-7. PubMed ID: 10229873
[TBL] [Abstract][Full Text] [Related]
49. Relationship between productive HIV-1 infection of macrophages and CCR5 utilization.
Hung CS; Pontow S; Ratner L
Virology; 1999 Nov; 264(2):278-88. PubMed ID: 10562492
[TBL] [Abstract][Full Text] [Related]
50. Position 22 of the V3 loop is associated with HIV infectivity.
Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
[TBL] [Abstract][Full Text] [Related]
51. CXCR4 and CCR5 regulation and expression patterns on T- and monocyte-macrophage cell lineages: implications for susceptibility to infection by HIV-1.
Joly M; Pinto JM
Math Biosci; 2005 May; 195(1):92-126. PubMed ID: 15893340
[TBL] [Abstract][Full Text] [Related]
52. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.
Dunfee RL; Thomas ER; Gorry PR; Wang J; Taylor J; Kunstman K; Wolinsky SM; Gabuzda D
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15160-5. PubMed ID: 17015824
[TBL] [Abstract][Full Text] [Related]
53. Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids.
Zou Z; Chastain A; Moir S; Ford J; Trandem K; Martinelli E; Cicala C; Crocker P; Arthos J; Sun PD
PLoS One; 2011; 6(9):e24559. PubMed ID: 21931755
[TBL] [Abstract][Full Text] [Related]
54. Vpx complementation of 'non-macrophage tropic' R5 viruses reveals robust entry of infectious HIV-1 cores into macrophages.
Mlcochova P; Watters SA; Towers GJ; Noursadeghi M; Gupta RK
Retrovirology; 2014 Mar; 11():25. PubMed ID: 24656066
[TBL] [Abstract][Full Text] [Related]
55. Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.
Brandenberg OF; Rusert P; Magnus C; Weber J; Böni J; Günthard HF; Regoes RR; Trkola A
Retrovirology; 2014 Sep; 11():75. PubMed ID: 25287422
[TBL] [Abstract][Full Text] [Related]
56. T-Cell-Mimicking Nanoparticles Can Neutralize HIV Infectivity.
Wei X; Zhang G; Ran D; Krishnan N; Fang RH; Gao W; Spector SA; Zhang L
Adv Mater; 2018 Nov; 30(45):e1802233. PubMed ID: 30252965
[TBL] [Abstract][Full Text] [Related]
57. Protein kinase C-delta regulates HIV-1 replication at an early post-entry step in macrophages.
Contreras X; Mzoughi O; Gaston F; Peterlin MB; Bahraoui E
Retrovirology; 2012 May; 9():37. PubMed ID: 22554282
[TBL] [Abstract][Full Text] [Related]
58. Human immunodeficiency virus 1 envelope-initiated G2-phase programmed cell death.
Kolesnitchenko V; Wahl LM; Tian H; Sunila I; Tani Y; Hartmann DP; Cossman J; Raffeld M; Orenstein J; Samelson LE; Cohen DI
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11889-93. PubMed ID: 8524869
[TBL] [Abstract][Full Text] [Related]
59. Preferential entry and productive infection of CD4 expressing lymphoid dendritic cells by macrophage-tropic HIV-1.
Cameron PU; Lowe MG; Sotzik F; Coughlan AF; Crowe SM; Shortman K
Adv Exp Med Biol; 1995; 378():429-33. PubMed ID: 8526110
[No Abstract] [Full Text] [Related]
60. Virus-host cell interactions in human immunodeficiency virus infections.
Gartner S; Ohashi K; Popovic M
Adv Exp Med Biol; 1991; 300():45-55. PubMed ID: 1723568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
